Abstract
Purpose of Review
This article introduces fundamental concepts in circadian biology and the neuroscience of sleep, reviews recent studies characterizing circadian rhythm and sleep disruption among critically ill patients and potentially links to functional outcomes, and draws upon existing literature to propose therapeutic strategies to mitigate those harms. Particular attention is given to patients with critical neurologic conditions and the unique environment of the neuro-intensive care unit.
Recent Findings
Circadian rhythm disruption is widespread among critically ill patients and sleep time is reduced and abnormally fragmented. There is a strong association between the degree of arousal suppression observed at the bedside and the extent of circadian disruption at the system (e.g., melatonin concentration rhythms) and cellular levels (e.g., core clock gene transcription rhythms). There is a paucity of electrographically normal sleep, and rest-activity rhythms are severely disturbed. Common care interventions such as neurochecks introduce unique disruptions in neurologic patients. There are no pharmacologic interventions proven to normalize circadian rhythms or restore physiologically normal sleep. Instead, interventions are focused on reducing pharmacologic and environmental factors that perpetuate disruption.
Summary
The intensive care environment introduces numerous potent disruptors to sleep and circadian rhythms. Direct neurologic injury and neuro-monitoring practices likely compound those factors to further derange circadian and sleep functions. In the absence of direct interventions to induce normalized rhythms and sleep, current therapy depends upon normalizing external stimuli.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Circadian Rhythms and Sleep − a Brief Introduction
Biological Rhythms and Circadian Physiology
Most organisms exhibit recurring physiologic processes that constitute biological rhythms. These rhythms occur in an extensive range of frequencies from infradian processes like annual hibernation and menstrual (i.e., monthly) ovulation, circadian or diurnal (i.e., daily) rhythms like sleep and wake, to ultradian (i.e., cyclical processes happening many times per day). Daily shifts between daytime and nighttime create marked changes in the environment. Most multicellular organisms have evolved physiologic processes to adapt to those predictable fluctuations. Circadian rhythms—those organized around the cycle of one day—are among the most complex and prominent. Many well-known biological rhythms, from sleep and wake cycles to blood pressure dipping and morning cortisol surges, result from entrainment to the circadian rhythm.
The suprachiasmatic nucleus (SCN) is often described as a central pacemaker for the circadian rhythm, but because all cells contain molecular clocks, body tissues are not “pacemaker-dependent” over short time intervals. The principal role of the SCN is to integrate relevant internal and external influences on circadian rhythm timing and to function as a central synchronizer. Individual cells maintain an internal clock comprised of a transcriptional feedback loop involving at least ten gene products [1]. Each cell therefore needs to be maintained in alignment with respect to timing (phase) in order to function in concert. This is accomplished by the SCN communicating signals to the peripheral circadian clocks in brain and other body tissues through hormonal rhythms and autonomic signals [2, 3]. The process of influencing the timing of the circadian rhythms is called entrainment, and factors that entrain rhythms are called zeitgebers (“time-givers”).
It is the rhythmic activity of the transcriptome that directly effectuates much of the physiology of the circadian rhythm. Nearly half of our protein-encoding genes demonstrate circadian transcription rhythms, mostly in an organ-specific pattern [4]. Brain arousal, sympathetic tone, cardiovascular function, coagulation, immune system activity, glycemic control and metabolism all exhibit circadian variability [5].
The most prominent natural phenomenon in the environment to direct daily rhythms is the cycling from light to dark. Light exposure on the retina is the most potent environmental zeitgeber in humans. Other known zeitgebers include enteral nutrient intake, physical exertion/exercise and activity rhythms, all of which reinforce rhythms in groups of social animals like human beings. Modern living conditions have overcome much of our need to be constrained by the natural environment, but these conditions have also introduced environmental and biochemical exposures that now confound the natural entrainment of the circadian rhythm. Artificial light at night, irregular rest, eating and activity patterns and substances that interfere with circadian signaling—from caffeine to medications like beta blockers—all introduce destabilizing signals to the body’s clocks.
Sleep and Sleep Impairment
The daily rhythm of sleep and active wakefulness is one of the many phenomena entrained by the circadian rhythm. In turn, brain functions such as memory consolidation and attention are secondarily influenced by sleep [6]. The initiation of sleep is principally regulated by two processes: the circadian rhythm and a sleep homeostat that increases sleep pressure as the duration of wake time increases. It is crucial to recognize that sleep is not simply the absence of wakefulness, but rather, a set of complex central nervous system processes that can be recognized in healthy subjects by physical manifestations (e.g., rapid eye movements) or electrographic biomarkers (e.g., sleep spindles, slow waves). Unconsciousness due to medications or severe systemic derangements is predominantly mediated by neuronal dysfunction or gamma-aminobutyric acid (GABA) receptor agonists, which do not stimulate the neural mechanisms for sleep induction. Therefore, the normal physiological processes that occur during healthy sleep are likely also impaired during this abnormal absence of wakefulness.
In otherwise healthy subjects, sleep timing and duration are more straightforward to measure than molecular rhythms. Much of the pathology that occurs from disrupting normal rhythms has been attributed to sleep disruption even if the pathophysiologic pathway mediating the abnormalities may not directly involve sleep. For example, glymphatic flow that clears metabolic waste from the brain has been described as a function linked to sleep; more recently, however, carefully structured experiments indicate that glymphatic flow is tightly regulated by the circadian rhythm but independent of arousal state (sleep/wake status) [7]. Sleep itself exerts little entrainment back on the circadian rhythm, but the behaviors that coincide with wakefulness (lights on, physical activity, eating) do, so sleep disruption can cause rhythm disruption. Consequently, it is reasonable to interpret literature identifying associations between sleep disruption and morbidity as likely mediated by circadian rhythm disruption. Optimizing sleep, therefore, should be understood broadly to mean optimizing sleep as well as all exposures that influence the circadian rhythm in order to maximize healthy function of the brain and body.
Circadian Rhythm and Sleep Disruption during Critical Illness
The consequences of sleep deprivation and circadian rhythm disruption have been extensively studied and are understood to be detrimental to health. Circadian and sleep health have been explored extensively in patients with chronic sleep disorders (e.g., obstructive sleep apnea) or under conditions of persistent rhythm disruptions (e.g., irregular shift work schedules). More recent research has evaluated sleep and rhythms in patients with critical illness and found that the circadian rhythm is rapidly disrupted with onset of critical illness [8•].
Polysomnography, which incorporates scalp electroencephalography with measurements of breathing and muscle tone, has been a preferred method for measuring sleep. Encephalopathy in the context of acute illness alters brain function in a way that makes usual sleep patterns unrecognizable, so alternative methods are often needed to assess sleep in acutely ill subjects, especially those with critical illness [9,10,11]. Activity quantification is the standard method for evaluating sleep and wake in animal models of circadian research [12]. Measurement of rest and activity by wrist actigraphy, often used as an alternative to polysomnography as a biomarker for sleep and wake, can be analyzed for rhythmicity characteristics [13]. Moreover, actigraphy can be analyzed with methods that are minimally confounded by bedrest, intravenous catheters and other physical constraints of hospitalization and is feasible and interpretable in critically ill patients [14••]. Analysis of wrist actigraphy in patients with sepsis and intracerebral hemorrhage has found that critically ill humans rapidly enter a state of behavioral quiescence with rest-activity rhythms that are suppressed or abolished in proportion to the degree of encephalopathy that is measurable at the bedside [14]. This phenomenon has previously been described in animal models with experimental injury or chemical physiologic stress, and there is evidence that the quiescence state is mediated by a dedicated neural pathway as part of a protective response [15, 16].
Melatonin, an endogenous hormone secreted primarily by the pineal gland after conversion from precursor serotonin, is the most commonly used and robust marker of circadian phase in humans and an important signal of circadian phase to peripheral tissues [17]. Melatonin secretion rapidly becomes abnormal in patients with neurologic or multisystem critical illnesses. As the degree of encephalopathy worsens into coma, melatonin secretion dampens [18]. Another major factor influencing melatonin secretion patterns is exposure to catecholamine vasopressors, which are commonly used in multiorgan failure cases and can induce severely supraphysiologic melatonin levels [18]. Melatonin is released by β-adrenergic stimulation on pineal cell membranes, and is thus sensitive to abnormal release from medications such as norepinephrine, or suppression from exposure to beta-adrenergic receptor antagonists (beta blockers) [19].
Data have emerged indicating that peripheral clocks — the cellular system of rhythmic transcriptome regulation — rapidly become disorganized during critical illness. Peripheral blood samples have shown that RNA transcripts of core clock gene products (most of which exhibit overt rhythmicity in healthy individuals) show diminished rhythmicity in critically ill patients [20••,21, 22]. Those core clock genes regulate transcription of many other genes, and methods have been developed to characterize rhythmicity and phase of the broader transcriptome [23]. Applying those methods to critically ill patients found abnormally diminished organization of the whole transcriptome compared to healthy subjects [14].
Finally, there are characteristics of the neurologic critical illness that merit particular attention. Projections between the retina, SCN, hypothalamus, pineal gland and autonomic pathways relay afferent information about zeitgeber exposures to the central clock and disseminate timing signals to peripheral clocks; direct injury to any of those neurological structures can produce sleep and circadian dysregulation. The rapid onset of transcriptomic dysrhythmia in peripheral clocks suggests that abnormal autonomic signals and inflammatory mediators quickly disrupt rhythms [20]. Second, monitoring strategies and specific therapies pose unique risks for disruption. For example, the potential role of neurochecks as mediators of harm through forced awakenings has received particular attention. Neurochecks are brief, standardized neurologic exams that are used ubiquitously in neurologic ICUs (neuroICUs) to monitor the evolution of symptoms and assess response to therapies in patients with brain and spinal cord injury [24]. The implementation of neurochecks in ICUs is variable, but prolonged exposure to many days of hourly awakening is fairly common [25•].
Effect of Circadian Rhythm and Sleep Disruption on ICU Outcomes
Confirming causality in critically ill patients is challenging in the context of myriad physiologic perturbations and medication exposures. There are no large randomized trials that specifically target a sleep or circadian therapy and demonstrate clear improvement in mortality or long-term functional outcomes. In the absence of high-level evidence, our understanding about the relationship between sleep and circadian pathology and post-intensive care outcomes is based on two sources: mechanistic research in other populations, and uncontrolled, observational studies identifying associations between sleep/circadian disruption and outcomes.
An episode of critical illness markedly worsens the trajectory of older adults’ functional status, causing new disability mediated by acquired symptoms in mood, sleep, cognition impairment, and physical function [26,27,28,29]. Post-Intensive Care Syndrome (PICS) describes a set of comorbidities affecting cognition, mental health and physical function that develop in the majority of patients after severe illnesses, often persisting as chronic disability [27]. Depending on the method of measurement and diagnostic threshold used, physical disability, cognitive impairment, depression, anxiety and sleep disturbance each occur in around 30–70% of ICU survivors, with substantial comorbid overlap [27, 30,31,32,33••]. These symptoms, in turn, are associated with worse health-related quality of life [34, 35]. The symptoms of PICS overlap substantially with the neurocognitive effects of sleep and circadian disorders, so interventions to minimize the extent of sleep and circadian disruption that develops during acute illness and to maximize the re-establishment of healthy sleep and rhythms are plausible strategies to prevent or mitigate PICS [36]. Prolonged sleep deprivation is an established source of physical and cognitive impairment—even in healthy study volunteers—which raises concern for round-the-clock care interventions that occur in the ICU.
Given the importance of peripheral clocks in homeostasis and normal function of other organ systems, rhythm disruptions may influence non-neurologic outcomes as well. For example, many immune functions are regulated by circadian rhythms. Circadian disruption may contribute to the development of acquired immunodeficiency that is observed to develop after several days of critical illness and leaves patients vulnerable to nosocomial infectious complications [37]. Drawing upon studies in other populations, circadian disruption likely impairs the function of many other systems, including endocrine-regulated processes, glycemic control and other metabolic pathways, autonomic and cardiac stability, lung function, renal clearance and liver function, the basis for which has been reviewed in details elsewhere [38]. In the remainder of this article, we will discuss the rationale for specific pharmacologic and environmental interventions that may attenuate sleep and circadian disruption in the ICU, with special attention to the neurologic population.
Pharmacological Strategies
Many medications used during intensive care management can directly or indirectly impact the central nervous system, as well as sleep (see Table 1). The first point to make regarding pharmacological strategies for optimizing sleep is that sedation (the absence of wakefulness) and sleep are not equivalent and likely involve different areas and networks within the brain [39]. Although there are many sedating medications that induce a clinical state resembling sleep, the relationship between sedation and sleep is complex and not fully understood, and patient sedation likely does not achieve restorative sleep.
In the neuroICU, we commonly use infusions for patient sedation, anxiolysis and analgesia, particularly in intubated patients. The most common of these include opioids, midazolam, propofol, dexmedetomidine, and ketamine. There are limited data describing the impact of opioids on sleep architecture, but in general, restorative sleep and the total sleep time are decreased [40]. Benzodiazepines are also known to reduce restorative sleep and REM, as well as decrease total sleep time. Additionally, benzodiazepine and opioid use are known risk factors for development of delirium [41, 42]. Dexmedetomidine studies are inconsistent in their effect on restorative sleep and sleep efficiency, though sleep spindles have been reported [43]. Given its alpha-2 activity and endogenous activity in non-REM sleep pathways, dexmedetomidine has been studied extensively as an agent to promote sleep. Early evaluations of dexmedetomidine in critically ill patients demonstrated increase sleep efficiency and improvement in sleep architecture [44, 45]. Unfortunately, these effects on sleep quality were not borne out in additional double-blind, randomized trials, though delirium may be decreased in patients receiving protocolized dexmedetomidine when compared with placebo [46, 47]. Specifically in comparison with propofol, major clinical trials have not shown a difference in measured clinical outcomes such as mortality and delirium, though sleep was not assessed in either the SPICE III or Mends study [48, 49]. Dexmedetomidine—like propofol—can be limited by bradycardia and hypotension [49]. Propofol’s impact on sleep has been studied extensively, but there is insufficient evidence to determine whether it improves sleep, and many studies show no differences in sleep efficiency or sleep fragmentation [40, 43, 50]. Lastly, ketamine may promote restorative slow wave sleep via the NMDA inhibitory pathway at higher doses, but also produces unconsciousness [51].
In terms of enteral pharmacologic agents, antipsychotic and antiepileptic medications both impact sleep. Typical antipsychotics such as haloperidol have been reported to decrease both REM latency and sleep fragmentation without noticeable suppression of REM or restorative sleep. Atypical antipsychotics increase total sleep time and sleep efficiency, and quetiapine may improve subjective sleep quality [40]. Epilepsy itself is known to alter sleep architecture, and anti-epileptic medications including phenytoin, phenobarbital, valproic acid, and levetiracetam all alter sleep architecture with most decreasing REM sleep without a reciprocal increase in slow wave restorative sleep [52].
We know that many medications used in the ICU negatively impact traditional sleep measures, but what remains unclear is whether there are pharmacological agents available to optimize sleep. Additional agents studied for their potential improvement in sleep are the melatonin receptor agonists, including melatonin and ramelteon. Melatonin reduces sleep latency, but when compared with placebo, there is a lack of effect on total sleep time, sleep efficiency, and sleep fragmentation [51, 53]. Melatonin is regulated in the USA as a dietary supplement rather than a prescription or over-the-counter drug, whereas other jurisdictions regulate melatonin as a prescription medication. As a consequence, melatonin formulation may contain doses that differ from the label or include a substantial quantity of serotonin [54]. A related MT1 and MT2 receptor agonist, ramelteon, is available at most institutions. Ramelteon also decreases sleep latency and may additionally improve sleep efficiency, total sleep time, and subjective sleep quality. When studied in critically ill patients without brain injury, ramelteon has been reported to decrease ICU duration, delirium incidence, and increase ventilator-free hours [55,56,57], though inconsistently across studies [58]. Importantly, ramelteon is a potent CYP1 and 2 inhibitor. Given that melatonin levels may be either abnormally suppressed or severely supraphysiologic in critically ill patients (depending on illness severity, environmental and medication exposures), a simplistic strategy of adding more melatonin at night is unlikely to be effective for all patients [18]. There may be a clearer role for melatonin to support circadian normalization during illness recovery.
Ultimately, there is lack of strong evidence for any pharmacological agent to promote sleep in the ICU. Yet, neuroactive medications are newly initiated in approximately 10% of critically ill patients admitted for greater than 24 h—most commonly melatonin agonists or antipsychotics—and continued for nearly three-quarters of nights that patients spend in the ICU [59]. This trend is concerning, especially because there is no pharmacological agent recommended by the PADAS guidelines to “promote sleep” [60, 61]. Our priority for pharmacological optimization may simply be eliminating polypharmacy and minimizing the use of sedative infusions and opioids.
Environmental and Zeitgeber Strategies
Strategies discussed herein leverage known zeitgebers that cue a person’s internal body clock. These strategies attempt to optimize sleep by normalizing the circadian rhythm—for instance, by promoting appropriate stimulation/rest environments, improving eating and drinking patterns, clustering care and ultimately, minimizing arousals.
Light/Dark and Quiet Time
Day-night light patterns are one of the most important circadian entrainment signals, and abnormal light exposure in the hospital is a major source of circadian disruption [62]. Light strongly suppresses melatonin secretion from the pineal gland (which peaks overnight in healthy individuals). Light levels in the hospital during the day are often too low to promote normal entrainment [63•,64 ]. In the ICU, light levels range from 30 to 165 lux during the day (compared with natural light, >4000 lux), but can also be as high as 1445 lux overnight, further contributing to circadian misalignment [63, 65, 66]. Prolonged intervals of eyelid closure during the day also reduces exposure to daytime light. Existing data suggest that inadequate daytime light is the principal abnormality driving day-night circadian dysregulation, and that efforts to minimize nighttime light without boosting daytime light may be insufficient to promote entrainment.
In addition to suboptimal day-night light levels, noise is also reported to be disruptive to sleep [62, 67]. In the ICU, noises are produced by people (e.g., talking), machines (e.g., alarms), and normal movements (e.g., doors opening and closing). The Environmental Protection Agency recommends hospital noise levels average less than 45 dB during the day and less than 35 dB at night; recorded levels in the ICU exceed these recommendations [68,69,70,71]. Unfortunately, there is a large degree of heterogeneity in studies of noise in the ICU, and it is currently impossible to quantify the extent to which noise contributes to sleep disruption and arousals among ICU patients [68]. Perhaps more important than absolute noise levels are changes in noise levels from baseline sound levels [68, 72, 73]. In this way, the sudden pump alarm may be more disturbing to a patient than the constant talking outside the room.
Feeding
Healthcare professionals should supply adequate nutrition to every patient unless prolongation of life is not in the patient’s goals of care [74, 75]. There are several methods for supplying enteral nutrition. In critically ill patients, however, the most common modalities used are continuous and intermittent/bolus feedings. Continuous feeding uses a pump to administer feeding nearly continuously throughout the 24-h period, whereas bolus and intermittent feeding generally supply a small volume of feeds multiple times throughout the day, e.g., every 4–6 h.
Continuous feeding may be well tolerated in brain injured patients when focusing on residual volumes and glucose variability, but poorly tolerated from a circadian standpoint [76]. Continuous feeding violates the body’s biological rhythm. When food availability is disconnected from the master clock (the SCN), metabolic processes regulated by nutritional inputs are also dysregulated and discordant [77, 78]. Therefore, intensivists should consider bolus or intermittent feeding, which more closely resembles “mealtime” feeds. Even so, bolus feeds are alone not the solution to circadian realignment; these feeds should also be given at appropriate times of the day (daytime-restricted feeds) while still meeting caloric requirements [79•]. In addition to its potential role in re-aligning the circadian rhythm, feeding at the physiologically correct time also promotes improved glycemic control and reduced inflammation, though there is a potential risk for aspiration debated in the literature [78, 80]. There is current controversy about the best methods for determining metabolic demands in the neuroICU, and further research is required to understand better nutritional initiation, advancement and metabolic monitoring in the neuroICU [81].
Clustered Care
Although vigilant monitoring of our critically ill patients in paramount, excessive or frequent patient interruptions can be detrimental. Some of these interruptions include lab draws, medication administration, vital sign checks, nursing care such as bathing and wound care, and radiographs. Critically ill patients can experience up to 8 care-related interruptions each hour during usual sleep time—with up to 50 throughout the nightshift hours—and one in five of these interactions results in an arousal or awakening when assessed by polysomnography [82,83,84]. Changes in ICU workflow to cluster care can be difficult to accomplish [85]. Recently, though, clustered care in the ICU has become more common-place and necessary since the COVID-19 pandemic began, and this bundling of care interventions may improve sleep and reduce delirium, with studies actively underway [43, 86,87,88].
Neurologic Assessments
Guidelines for care of patients with acute brain injury recommend “frequent” neuromonitoring, though stop short of defining a frequency or duration of neurochecks [89,90,91]. This has resulted in variation in neuromonitoring practices across the country, with a general adoption of hourly (Q1) or every-other-hour (Q2) neurochecks as “frequent” monitoring [92]. The extent to which frequent neuroassessments contribute to circadian derangement and sleep impairment is uncertain.
Although the link between disruptions in the abnormal sleep seen in brain-injured patients and poor outcomes is much more tenuous than the clear link between secondary brain injury and poor outcomes, frequent neurochecks may have negative consequences, particularly when prolonged. In an evaluation of approximately 9500 hourly neurocheck orders in nearly 9000 patients with acute brain injury at a tertiary academic medical center, it was noted that a substantial proportion of patients are maintained on continuous hourly neurochecks for >3 days (20%) and >7 days (7%) [25]. A smaller but still non-trivial number of patients (3%) were maintained on hourly neurochecks continuously for >14 days. Additionally, one-quarter of hourly neurochecks were transitioned to no neurochecks at the time of discontinuation, suggesting that they were likely unnecessary for the full duration that they were ordered.
Taken together, the implication is that there is room for improvement in our serial examinations, and we must be more mindful about the frequency we choose and the duration for which they are ordered. Generally, we have an appreciation for the disease- and severity-specific risks of neurodeterioration, and we must focus on how we can monitor the complexity of the brain perhaps more intelligently [24, 93, 94]. The ideal monitoring system is likely one that balances risk and need in a personalized and individualized manner rather than strict adherence to protocols, tapering neurocheck frequency as the risk of acute deterioration wanes.
Conclusion
Circadian rhythms organize a vast array of biological processes that must remain synchronized to function effectively. Nearly all tissues are regulated by a cellular-level molecular clock and demonstrate unique patterns of gene transcription rhythms that effect biological rhythms. Wake and sleep describe brain states comprising the sets of complex processes of the central nervous system’s circadian rhythm expression, and disruption of the sleep versus wake pattern both causes and reflects brain dysfunction. Abnormal exposures in the ICU environment including medications, feeding strategies, light, noise and arousals disrupt the central circadian rhythm and the hormonal and autonomic signals that entrain the peripheral clocks into synchrony. Strategies to reduce harm from sleep and circadian disruption begin with reducing mistimed stimuli with simple steps, such as: minimizing nighttime light and arousals and increasing daytime light, restricting enteral nutrition to daytime and preferably blousing feeds to simulate meals, and minimizing medications that interfere with rhythms. Sedating medications do not activate physiologically normal sleep and are unlikely to be restorative. It is more promising to reduce disruptive factors and promote circadian therapies aimed at entraining a normal rhythm during illness recovery.
References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Cox KH, Takahashi JS. Circadian clock genes and the transcriptional architecture of the clock mechanism. J Mol Endocrinol. 2019;63(4):R93–102. https://doi.org/10.1530/JME-19-0153
Vujovic N, Gooley JJ, Jhou TC, Saper CB. Projections from the subparaventricular zone define four channels of output from the circadian timing system. J Comp Neurol. 2015;523(18):2714–37. https://doi.org/10.1002/cne.23812
Barclay JL, Tsang AH, Oster H. Interaction of central and peripheral clocks in physiological regulation. Prog Brain Res. 2012;199:163–81. https://doi.org/10.1016/B978-0-444-59427-3.00030-7
Zhang R, Lahens NF, Ballance HI, Hughes ME, Hogenesch JB. A circadian gene expression atlas in mammals: implications for biology and medicine. Proc Natl Acad Sci USA. 2014;111(45):16219–24. https://doi.org/10.1073/pnas.1408886111
Chan MC, Spieth PM, Quinn K, Parotto M, Zhang H, Slutsky AS. Circadian rhythms: from basic mechanisms to the intensive care unit. Crit Care Med. 2012;40(1):246–53. https://doi.org/10.1097/CCM.0b013e31822f0abe
Nir Y, Andrillon T, Marmelshtein A, Suthana N, Cirelli C, Tononi G, et al. Selective neuronal lapses precede human cognitive lapses following sleep deprivation. Nat Med. 2017;23(12):1474–80. https://doi.org/10.1038/nm.4433
Hablitz LM, Plá V, Giannetto M, Vinitsky HS, Stæger FF, Metcalfe T, et al. Circadian control of brain glymphatic and lymphatic fluid flow. Nat Commun. 2020;11(1):4411. https://doi.org/10.1038/s41467-020-18115-2
• Telias I, Wilcox ME. Sleep and circadian rhythm in critical illness. Crit Care. 2019;23(1):82. https://doi.org/10.1186/s13054-019-2366-0. Detailed, broad scope review of recent studies measuring sleep and rhythm disruption that occurs during critical illness.
Watson PL. Measuring sleep in critically ill patients: beware the pitfalls. Crit Care. 2007;11(4):159. https://doi.org/10.1186/cc6094
Watson PL, Pandharipande P, Gehlbach BK, Thompson JL, Shintani AK, Dittus BS, et al. Atypical sleep in ventilated patients: empirical electroencephalography findings and the path toward revised ICU sleep scoring criteria. Crit Care Med. 2013;41(8):1958–67. https://doi.org/10.1097/CCM.0b013e31828a3f75
Foreman B, Westwood AJ, Claassen J, Bazil CW. Sleep in the neurological intensive care unit: feasibility of quantifying sleep after melatonin supplementation with environmental light and noise reduction. J Clin Neurophysiol. 2015;32(1):66–74. https://doi.org/10.1097/WNP.0000000000000110
Trojanowski NF, Raizen DM. Call it Worm Sleep. Trends Neurosci. 2016;39(2):54–62. https://doi.org/10.1016/j.tins.2015.12.005
Pan W, Song Y, Kwak S, Yoshida S, Yamamoto Y. Quantitative evaluation of the use of actigraphy for neurological and psychiatric disorders. Behav Neurol. 2014;2014: 897282. https://doi.org/10.1155/2014/897282
•• Maas MB, Lizza BD, Kim M, Abbott SM, Gendy M, Reid KJ, et al. Stress-induced behavioral quiescence and abnormal rest-activity rhythms during critical illness. Crit Care Med. 2020;48(6):862–71. https://doi.org/10.1097/CCM.0000000000004334. Study measuring sleep/rest‐activity circadian rhythm and ultradian rhythm disturbances in a large sample of critically ill patients including approximately 50 neurologic critical illness patients.
Trojanowski NF, Nelson MD, Flavell SW, Fang-Yen C, Raizen DM. Distinct mechanisms underlie quiescence during two caenorhabditis elegans sleep-like states. J Neurosci. 2015;35(43):14571–84. https://doi.org/10.1523/JNEUROSCI.1369-15.2015
Hill AJ, Mansfield R, Lopez JM, Raizen DM, Van Buskirk C. Cellular stress induces a protective sleep-like state in C. elegans. Curr Biol. 2014;24(20):2399-405. https://doi.org/10.1016/j.cub.2014.08.040
Benloucif S, Burgess HJ, Klerman EB, Lewy AJ, Middleton B, Murphy PJ, et al. Measuring melatonin in humans. J Clin Sleep Med. 2008;4(1):66–9.
Maas MB, Lizza BD, Abbott SM, Liotta EM, Gendy M, Eed J, et al. Factors disrupting melatonin secretion rhythms during critical illness. Crit Care Med. 2020;48(6):854–61. https://doi.org/10.1097/CCM.0000000000004333
Moore RY. Neural control of the pineal gland. Behav Brain Res. 1996;73(1–2):125–30.
•• Maas MB, Iwanaszko M, Lizza BD, Reid KJ, Braun RI, Zee PC. Circadian gene expression rhythms during critical illness. Crit Care Med. 2020;48(12):e1294–9. https://doi.org/10.1097/CCM.0000000000004697. Study measuring rhythm disturbances in gene expression rhythms, a measure of peripheral tissue clock activity, in critically ill patients including neurologic critical illnesses.
Diaz E, Diaz I, Del Busto C, Escudero D, Pérez S. Clock genes disruption in the intensive care unit. J Intensive Care Med. 2020;35(12):1497–504. https://doi.org/10.1177/0885066619876572
Lachmann G, Ananthasubramaniam B, Wünsch VA, Scherfig LM, von Haefen C, Knaak C, et al. Circadian rhythms in septic shock patients. Ann Intensive Care. 2021;11(1):64. https://doi.org/10.1186/s13613-021-00833-5
Braun R, Kath WL, Iwanaszko M, Kula-Eversole E, Abbott SM, Reid KJ, et al. Universal method for robust detection of circadian state from gene expression. Proc Natl Acad Sci USA. 2018;115(39):E9247–56. https://doi.org/10.1073/pnas.1800314115
Maas MB, Rosenberg NF, Kosteva AR, Bauer RM, Guth JC, Liotta EM, et al. Surveillance neuroimaging and neurologic examinations affect care for intracerebral hemorrhage. Neurology. 2013;81(2):107–12. https://doi.org/10.1212/WNL.0b013e31829a33e4
• LaBuzetta JN, Hirshman BR, Malhotra A, Owens RL, Kamdar BB. Practices and patterns of hourly neurochecks: analysis of 8,936 patients with neurological injury. J Intensive Care Med. 2021. https://doi.org/10.1177/08850666211029220. Large cohort analysis of the practice patterns implementing brief neurologic assessments (“neurochecks”) in different patient populations and specialized intensive care units.
Ferrante LE, Pisani MA, Murphy TE, Gahbauer EA, Leo-Summers LS, Gill TM. Functional trajectories among older persons before and after critical illness. JAMA Intern Med. 2015;175(4):523–9. https://doi.org/10.1001/jamainternmed.2014.7889
Marra A, Pandharipande PP, Girard TD, Patel MB, Hughes CG, Jackson JC, et al. Co-occurrence of post-intensive care syndrome problems among 406 survivors of critical illness. Crit Care Med. 2018;46(9):1393–401. https://doi.org/10.1097/CCM.0000000000003218
Major ME, Kwakman R, Kho ME, Connolly B, McWilliams D, Denehy L, et al. Surviving critical illness: what is next? An expert consensus statement on physical rehabilitation after hospital discharge. Crit Care. 2016;20(1):354. https://doi.org/10.1186/s13054-016-1508-x
Hopkins RO, Suchyta MR, Farrer TJ, Needham D. Improving post-intensive care unit neuropsychiatric outcomes: understanding cognitive effects of physical activity. Am J Respir Crit Care Med. 2012;186(12):1220–8. https://doi.org/10.1164/rccm.201206-1022CP
Pandharipande PP, Girard TD, Jackson JC, Morandi A, Thompson JL, Pun BT, et al. Long-term cognitive impairment after critical illness. N Engl J Med. 2013;369(14):1306–16. https://doi.org/10.1056/NEJMoa1301372
Jackson JC, Mitchell N, Hopkins RO. Cognitive functioning, mental health, and quality of life in ICU survivors: an overview. Crit Care Clin. 2009;25(3):615-28, x. https://doi.org/10.1016/j.ccc.2009.04.005
Parker AM, Sricharoenchai T, Raparla S, Schneck KW, Bienvenu OJ, Needham DM. Posttraumatic stress disorder in critical illness survivors: a metaanalysis. Crit Care Med. 2015;43(5):1121–9. https://doi.org/10.1097/CCM.0000000000000882
•• Altman MT, Knauert MP, Pisani MA. Sleep disturbance after hospitalization and critical illness: a systematic review. Ann Am Thorac Soc. 2017;14(9):1457–68. https://doi.org/10.1513/AnnalsATS.201702-148SR. Review of studies measuring sleep disturbance in survivors of hospitalization and critical illness in the early postdischarge period.
Maley JH, Brewster I, Mayoral I, Siruckova R, Adams S, McGraw KA, et al. Resilience in survivors of critical illness in the context of the survivors’ experience and recovery. Ann Am Thorac Soc. 2016;13(8):1351–60. https://doi.org/10.1513/AnnalsATS.201511-782OC
Oeyen SG, Vandijck DM, Benoit DD, Annemans L, Decruyenaere JM. Quality of life after intensive care: a systematic review of the literature. Crit Care Med. 2010;38(12):2386–400. https://doi.org/10.1097/CCM.0b013e3181f3dec5
LaBuzetta JN, Rosand J, Vranceanu AM. Review: Post-intensive care syndrome: unique challenges in the neurointensive care unit. Neurocrit Care. 2019;31(3):534–45. https://doi.org/10.1007/s12028-019-00826-0
Dengler V, Westphalen K, Koeppen M. Disruption of circadian rhythms and sleep in critical illness and its impact on innate immunity. Curr Pharm Des. 2015;21(24):3469–76. https://doi.org/10.2174/1381612821666150706105034
Chang VA, Owens RL, LaBuzetta JN. Impact of sleep deprivation in the neurological intensive care unit: a narrative review. Neurocrit Care. 2020;32(2):596–608. https://doi.org/10.1007/s12028-019-00795-4
Li Y, Wang S, Pan C, Xue F, Xian J, Huang Y, et al. Comparison of NREM sleep and intravenous sedation through local information processing and whole brain network to explore the mechanism of general anesthesia. PLoS One. 2018;13(2): e0192358. https://doi.org/10.1371/journal.pone.0192358
Oldham M, Pisani MA. Sedation in critically ill patients. Crit Care Clin. 2015;31(3):563–87. https://doi.org/10.1016/j.ccc.2015.03.010
Pisani MA, Murphy TE, Araujo KL, Slattum P, Van Ness PH, Inouye SK. Benzodiazepine and opioid use and the duration of intensive care unit delirium in an older population. Crit Care Med. 2009;37(1):177–83. https://doi.org/10.1097/CCM.0b013e318192fcf9
Zaal IJ, Devlin JW, Hazelbag M, Klein Klouwenberg PM, van der Kooi AW, Ong DS, et al. Benzodiazepine-associated delirium in critically ill adults. Intensive Care Med. 2015;41(12):2130–7. https://doi.org/10.1007/s00134-015-4063-z
Dorsch JJ, Martin JL, Malhotra A, Owens RL, Kamdar BB. Sleep in the intensive care unit: strategies for improvement. Semin Respir Crit Care Med. 2019;40(5):614–28. https://doi.org/10.1055/s-0039-1698378
Lu W, Fu Q, Luo X, Fu S, Hu K. Effects of dexmedetomidine on sleep quality of patients after surgery without mechanical ventilation in ICU. Medicine (Baltimore). 2017;96(23): e7081. https://doi.org/10.1097/MD.0000000000007081
Wu XH, Cui F, Zhang C, Meng ZT, Wang DX, Ma J, et al. Low-dose dexmedetomidine improves sleep quality pattern in elderly patients after noncardiac surgery in the intensive care unit: a pilot randomized controlled trial. Anesthesiology. 2016;125(5):979–91. https://doi.org/10.1097/ALN.0000000000001325
Skrobik Y, Duprey MS, Hill NS, Devlin JW. Low-dose nocturnal dexmedetomidine prevents ICU delirium. A randomized, placebo-controlled trial. Am J Respir Crit Care Med. 2018;197(9):1147-56. https://doi.org/10.1164/rccm.201710-1995OC
Su X, Meng ZT, Wu XH, Cui F, Li HL, Wang DX, et al. Dexmedetomidine for prevention of delirium in elderly patients after non-cardiac surgery: a randomised, double-blind, placebo-controlled trial. Lancet. 2016;388(10054):1893–902. https://doi.org/10.1016/S0140-6736(16)30580-3
Hughes CG, Mailloux PT, Devlin JW, Swan JT, Sanders RD, Anzueto A, et al. Dexmedetomidine or propofol for sedation in mechanically ventilated adults with sepsis. N Engl J Med. 2021;384(15):1424–36. https://doi.org/10.1056/NEJMoa2024922
Shehabi Y, Howe BD, Bellomo R, Arabi YM, Bailey M, Bass FE, et al. Early sedation with dexmedetomidine in critically Ill patients. N Engl J Med. 2019;380(26):2506–17. https://doi.org/10.1056/NEJMoa1904710
Lewis SR, Schofield-Robinson OJ, Alderson P, Smith AF. Propofol for the promotion of sleep in adults in the intensive care unit. Cochrane Database Syst Rev. 2018;1:CD012454. https://doi.org/10.1002/14651858.CD012454.pub2
Tiruvoipati R, Mulder J, Haji K. Improving sleep in intensive care unit: an overview of diagnostic and therapeutic options. J Patient Exp. 2020;7(5):697–702. https://doi.org/10.1177/2374373519882234
Jain SV, Glauser TA. Effects of epilepsy treatments on sleep architecture and daytime sleepiness: an evidence-based review of objective sleep metrics. Epilepsia. 2014;55(1):26–37. https://doi.org/10.1111/epi.12478
Lewandowska K, Malkiewicz MA, Sieminski M, Cubala WJ, Winklewski PJ, Medrzycka-Dabrowska WA. The role of melatonin and melatonin receptor agonist in the prevention of sleep disturbances and delirium in intensive care unit - a clinical review. Sleep Med. 2020;69:127–34. https://doi.org/10.1016/j.sleep.2020.01.019
Erland LA, Saxena PK. Melatonin natural health products and supplements: presence of serotonin and significant variability of melatonin content. J Clin Sleep Med. 2017;13(2):275–81. https://doi.org/10.5664/jcsm.6462
Hatta K, Kishi Y, Wada K, Takeuchi T, Hashimoto N, Suda K, et al. Real-world effectiveness of ramelteon and suvorexant for delirium prevention in 948 patients with delirium risk factors. J Clin Psychiatry. 2019;81(1). https://doi.org/10.4088/JCP.19m12865
Nishikimi M, Numaguchi A, Takahashi K, Miyagawa Y, Matsui K, Higashi M, et al. Effect of administration of ramelteon, a melatonin receptor agonist, on the duration of stay in the ICU: a single-center randomized placebo-controlled trial. Crit Care Med. 2018;46(7):1099–105. https://doi.org/10.1097/CCM.0000000000003132
Thom R, Bui M, Rosner B, Teslyar P, Levy-Carrick N, Wolfe D, et al. Ramelteon is not associated with improved outcomes among critically Ill delirious patients: a single-center retrospective cohort study. Psychosomatics. 2019;60(3):289–97. https://doi.org/10.1016/j.psym.2018.07.015
Jaiswal SJ, Vyas AD, Heisel AJ, Ackula H, Aggarwal A, Kim NH, et al. Ramelteon for prevention of postoperative delirium: a randomized controlled trial in patients undergoing elective pulmonary thromboendarterectomy. Crit Care Med. 2019;47(12):1751–8. https://doi.org/10.1097/CCM.0000000000004004
Hamidi A, Roberts RJ, Weinhouse GL, Szumita PM, Degrado JR, Dube KM, et al. Characterization of nocturnal neuroactive medication use and related sleep documentation in critically Ill adults. Crit Care Explor. 2021;3(3): e0367. https://doi.org/10.1097/CCE.0000000000000367
Devlin JW, Skrobik Y, Gelinas C, Needham DM, Slooter AJC, Pandharipande PP, et al. Clinical Practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med. 2018;46(9):e825–73. https://doi.org/10.1097/CCM.0000000000003299
Devlin JW, Skrobik Y, Gelinas C, Needham DM, Slooter AJC, Pandharipande PP, et al. Executive summary: clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med. 2018;46(9):1532–48. https://doi.org/10.1097/CCM.0000000000003259
Jaiswal SJ, Garcia S, Owens RL. Sound and light levels are similarly disruptive in ICU and non-ICU wards. J Hosp Med. 2017;12(10):798-804. https://doi.org/10.12788/jhm.2826
• Fan EP, Abbott SM, Reid KJ, Zee PC, Maas MB. Abnormal environmental light exposure in the intensive care environment. J Crit Care. 2017;40:11–4. https://doi.org/10.1016/j.jcrc.2017.03.002. Data demonstrating the extent of abnormal (low intensity and low rhythmicity) light exposure in the intensive care environment.
Gehlbach BK, Chapotot F, Leproult R, Whitmore H, Poston J, Pohlman M, et al. Temporal disorganization of circadian rhythmicity and sleep-wake regulation in mechanically ventilated patients receiving continuous intravenous sedation. Sleep. 2012;35(8):1105–14. https://doi.org/10.5665/sleep.1998
Meyer TJ, Eveloff SE, Bauer MS, Schwartz WA, Hill NS, Millman RP. Adverse environmental conditions in the respiratory and medical ICU settings. Chest. 1994;105(4):1211–6. https://doi.org/10.1378/chest.105.4.1211
Verceles AC, Liu X, Terrin ML, Scharf SM, Shanholtz C, Harris A, et al. Ambient light levels and critical care outcomes. J Crit Care. 2013;28(1):110 e1-8. https://doi.org/10.1016/j.jcrc.2012.04.012
Kamdar BB, Needham DM, Collop NA. Sleep deprivation in critical illness: its role in physical and psychological recovery. J Intensive Care Med. 2012;27(2):97–111. https://doi.org/10.1177/0885066610394322
Horsten S, Reinke L, Absalom AR, Tulleken JE. Systematic review of the effects of intensive-care-unit noise on sleep of healthy subjects and the critically ill. Br J Anaesth. 2018;120(3):443–52. https://doi.org/10.1016/j.bja.2017.09.006
Tainter CR, Levine AR, Quraishi SA, Butterly AD, Stahl DL, Eikermann M, et al. Noise levels in surgical ICUs are consistently above recommended standards. Crit Care Med. 2016;44(1):147–52. https://doi.org/10.1097/CCM.0000000000001378
Darbyshire JL, Young JD. An investigation of sound levels on intensive care units with reference to the WHO guidelines. Crit Care. 2013;17(5):R187. https://doi.org/10.1186/cc12870
Elbaz M, Leger D, Sauvet F, Champigneulle B, Rio S, Strauss M, et al. Sound level intensity severely disrupts sleep in ventilated ICU patients throughout a 24-h period: a preliminary 24-h study of sleep stages and associated sound levels. Ann Intensive Care. 2017;7(1):25. https://doi.org/10.1186/s13613-017-0248-7
Stanchina ML, Abu-Hijleh M, Chaudhry BK, Carlisle CC, Millman RP. The influence of white noise on sleep in subjects exposed to ICU noise. Sleep Med. 2005;6(5):423–8. https://doi.org/10.1016/j.sleep.2004.12.004
Buxton OM, Ellenbogen JM, Wang W, Carballeira A, O’Connor S, Cooper D, et al. Sleep disruption due to hospital noises: a prospective evaluation. Ann Intern Med. 2012;157(3):170–9. https://doi.org/10.7326/0003-4819-157-3-201208070-00472
Stroud M, Duncan H, Nightingale J, British Society of G. Guidelines for enteral feeding in adult hospital patients. Gut. 2003;52 Suppl 7:vii1-vii12. https://doi.org/10.1136/gut.52.suppl_7.vii1
Peng J, Volbers B, Sprugel MI, Hoelter P, Engelhorn T, Jiang Y, et al. Influence of early enteral nutrition on clinical outcomes in neurocritical care patients with intracerebral hemorrhage. Front Neurol. 2021;12: 665791. https://doi.org/10.3389/fneur.2021.665791
Rhoney DH, Parker D Jr, Formea CM, Yap C, Coplin WM. Tolerability of bolus versus continuous gastric feeding in brain-injured patients. Neurol Res. 2002;24(6):613–20. https://doi.org/10.1179/016164102101200456
Jobanputra AM, Scharf MT, Androulakis IP, Sunderram J. Circadian disruption in critical illness. Front Neurol. 2020;11:820. https://doi.org/10.3389/fneur.2020.00820
Rothschild J, Lagakos W. Implications of enteral and parenteral feeding times: considering a circadian picture. JPEN J Parenter Enteral Nutr. 2015;39(3):266–70. https://doi.org/10.1177/0148607114551026
• Sunderram J, Sofou S, Kamisoglu K, Karantza V, Androulakis IP. Time-restricted feeding and the realignment of biological rhythms: translational opportunities and challenges. J Transl Med. 2014;12:79. https://doi.org/10.1186/1479-5876-12-79. Review of data describing the influence of feeding timing on biological rhythms along with therapeutic implications.
Ichimaru S. Methods of enteral nutrition administration in critically Ill patients: continuous, cyclic, intermittent, and bolus feeding. Nutr Clin Pract. 2018;33(6):790–5. https://doi.org/10.1002/ncp.10105
Tavarez T, Roehl K, Koffman L. Nutrition in the neurocritical care unit: a new frontier. Curr Treat Options Neurol. 2021;23(5):16. https://doi.org/10.1007/s11940-021-00670-8
Gabor JY, Cooper AB, Crombach SA, Lee B, Kadikar N, Bettger HE, et al. Contribution of the intensive care unit environment to sleep disruption in mechanically ventilated patients and healthy subjects. Am J Respir Crit Care Med. 2003;167(5):708–15. https://doi.org/10.1164/rccm.2201090
Tamburri LM, DiBrienza R, Zozula R, Redeker NS. Nocturnal care interactions with patients in critical care units. Am J Crit Care. 2004;13(2):102-12; quiz 14-5.
Celik S, Oztekin D, Akyolcu N, Issever H. Sleep disturbance: the patient care activities applied at the night shift in the intensive care unit. J Clin Nurs. 2005;14(1):102–6. https://doi.org/10.1111/j.1365-2702.2004.01010.x
Knauert MP, Redeker NS, Yaggi HK, Bennick M, Pisani MA. Creating naptime: an overnight, nonpharmacologic intensive care unit sleep promotion protocol. J Patient Exp. 2018;5(3):180–7. https://doi.org/10.1177/2374373517747242
Newby JC, Mabry MC, Carlisle BA, Olson DM, Lane BE. Reflections on nursing ingenuity during the COVID-19 pandemic. J Neurosci Nurs. 2020;52(5):E13–6. https://doi.org/10.1097/JNN.0000000000000525
Kamdar BB, Kamdar BB, Needham DM. Bundling sleep promotion with delirium prevention: ready for prime time? Anaesthesia. 2014;69(6):527–31. https://doi.org/10.1111/anae.12686
Kamdar BB, Martin JL, Needham DM, Ong MK. Promoting sleep to improve delirium in the ICU. Crit Care Med. 2016;44(12):2290–1. https://doi.org/10.1097/CCM.0000000000001982
Connolly ES Jr, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association. Stroke. 2012;43(6):1711–37. https://doi.org/10.1161/STR.0b013e3182587839
Hemphill JC 3rd, Greenberg SM, Anderson CS, Becker K, Bendok BR, Cushman M, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46(7):2032–60. https://doi.org/10.1161/STR.0000000000000069
Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019;50(12):e344–418. https://doi.org/10.1161/STR.0000000000000211
LaBuzetta JN. Personal communication: Variability in Q1 versus Q2 Practices Following Acute Brain Injury Among 18 Neurocritical Care Units Across the USA, including: UCLA Medical Center, Massachusetts General Hospital, Brigham and Womens Hospital, Beth Israel Deaconess Medical Center, University of Pittsburgh, Yale New Haven, Duke University, University of Miami, Shock Trauma, University of Michigan, Brown University, New York University, Chriastiana Care, Rush University, Chicago Catholic, UT Austin, University of Washington, University of Colorado Denver. Among 18 academic neurocritical care ICUs across the Unites States, 7 performed Q1 neurochecks for 24 hours regardless of stability. 2 performed Q2 upon admission to the ICU. All others performed Q1 until radiographic stability was determined, then transitioned to Q2. edMay 2021.
Lord AS, Gilmore E, Choi HA, Mayer SA, Collaboration V-I. Time course and predictors of neurological deterioration after intracerebral hemorrhage. Stroke. 2015;46(3):647–52. https://doi.org/10.1161/STROKEAHA.114.007704
McLaughlin DC, Hartjes TM, Freeman WD. Sleep deprivation in neurointensive care unit patients from serial neurological checks: how much is too much? J Neurosci Nurs. 2018;50(4):205–10. https://doi.org/10.1097/JNN.0000000000000378
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Jamie Nicole LaBuzetta declares that she has no conflict of interest. Atul Malhotra declares that he has no conflict of interest. Phyllis C. Zee declares that she has no conflict of interest. Matthew B. Maas declares that he has no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Critical Care Neurology
Rights and permissions
About this article
Cite this article
LaBuzetta, J.N., Malhotra, A., Zee, P.C. et al. Optimizing Sleep and Circadian Health in the NeuroICU. Curr Treat Options Neurol 24, 309–325 (2022). https://doi.org/10.1007/s11940-022-00724-5
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11940-022-00724-5